tiprankstipranks
Harmony Biosciences Unveils Investor Presentation with Future Insights
PremiumCompany AnnouncementsHarmony Biosciences Unveils Investor Presentation with Future Insights
3M ago
Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
PremiumPress Releases
Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
3M ago
Harmony Biosciences sees FY24 net product revenue $700M-$720M
PremiumThe Fly
Harmony Biosciences sees FY24 net product revenue $700M-$720M
3M ago
Harmony Biosciences begins Phase 3 registrational study of pitolisant in PWS
PremiumThe FlyHarmony Biosciences begins Phase 3 registrational study of pitolisant in PWS
4M ago
Harmony Biosciences management to meet with Oppenheimer
PremiumThe Fly
Harmony Biosciences management to meet with Oppenheimer
4M ago
Harmony Biosciences management to meet with Oppenheimer
PremiumThe Fly
Harmony Biosciences management to meet with Oppenheimer
4M ago
Harmony Biosciences Releases Investor Presentation Update
PremiumCompany AnnouncementsHarmony Biosciences Releases Investor Presentation Update
5M ago
Harmony Biosciences reports Q4 adjusted EPS 73c, consensus 48c
PremiumThe Fly
Harmony Biosciences reports Q4 adjusted EPS 73c, consensus 48c
5M ago
Harmony Biosciences: FDA grants priority review for sNDA for WAKIX
PremiumThe Fly
Harmony Biosciences: FDA grants priority review for sNDA for WAKIX
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100